Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/24/2020
NIFDC Issues the 2019 National Drug Sample Inspection Annual Report
3/24/2020
Context and Tyligand Partner to Advance Cancer Therapy
3/20/2020
Recent Executive Moves
3/20/2020
NMPA Suspends Sales and Use of Supriya's Chlorphenamine Maleate Follow...
3/20/2020
Hansoh Pharma's Ameile (Almonertinib) Approved in China for Non-Small ...
3/19/2020
BMS Granted 3rd Indication of Opdivo to Treat Gastric Cancer in China
3/18/2020
Snapshot of Chinese Urban Rep Hospital Drug Market in 2019
3/18/2020
Snapshot of Chinese VMS OTC Market in MAT 09/2019
3/18/2020
ChemPartner Opens New Global Operation Center in Shanghai
3/18/2020
China Initiates Clinical Research on Stem Cell Therapy against COVID-1...
3/18/2020
China Reports Good Clinical Results of Fujifilm Drug against Covid-19
3/17/2020
I-Mab Announces Development of TJM2 to Treat COVID-19 Related Cytokine...
3/16/2020
U.S. Eyes Puerto Rico As Alternative to Chinese APIs
3/13/2020
Recent Executive Moves
3/13/2020
New Indication of XiAn Janssen's STELARA (ustekinumab) Approved in Chi...
3/12/2020
Biogen and Vir Biotechnology to Collaborate to Find a Treatment for th...
3/12/2020
Brii Bio and Columbia University Sign MOU to Fund Research of Coronavi...
3/12/2020
WuXi AppTec Wuhan Site Resumed Operation
3/12/2020
Takeda's Entyvio (vedolizumab) Approved in China for Ulcerative Coliti...
3/12/2020
Review of Chinese Pharmaceutical Industry Performance in 2019
3/12/2020
Highlights of China's New Implementing Regulations for the Foreign Inv...
3/12/2020
China Unveils New Measures to Keep Foreign Trade, Investment Stable
3/12/2020
Clearside and Arctic Vision Enter License Deal for Edema Drug XIPERE i...
3/11/2020
XtalPi Announces Strategic Collaboration with Porton for Drug Crystall...
3/11/2020
Pharma Faces Clinical Trial Disruptions by Coronavirus Outbreak in Chi...
3/11/2020
EMA to Consider Coronavirus' Impact on EU Medicines Supply
3/11/2020
WuXi Biologics Completes Biologics Manufacturing Facility in Ireland
3/11/2020
Global Companies Expand the Reach of Their Cancer Drugs in China
3/11/2020
Trump to Issue Executive Order Aimed At Ending Medical and API Relianc...
3/11/2020
The Coronavirus Long Battle: Trump Admin To Attack China’s Pharmaceut...
Page:
124
/
360
Total number of articles:
10791
:
[First]
[<<]
[122]
[123]
[124]
[125]
[126]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit